Target intelligence / Profile preview

Electrophilic xenobiotics and endogenous electrophilic metabolites

Molecular classification
Other
01

Overview

Electrophilic xenobiotics and endogenous electrophilic metabolites are chemically reactive molecules characterized by electron-deficient centers that readily form covalent bonds with nucleophilic sites on cellular macromolecules like DNA and proteins [1]. Endogenous electrophiles, such as 4-hydroxynonenal, often arise from lipid peroxidation or oxidative stress, while xenobiotic electrophiles are frequently generated through the metabolic activation of drugs, such as the formation of NAPQI from paracetamol [2]. These species are not traditional therapeutic targets like receptors or enzymes; rather, they are reactive agents that cause cellular damage and trigger protective signaling pathways [3]. The primary biological sensor for these molecules is the Keap1-Nrf2 system, which orchestrates the antioxidant response to neutralize electrophilic stress [4]. Pharmacological strategies involve the use of nucleophilic scavengers like N-acetylcysteine to directly bind and inactivate these species or the use of Nrf2 activators to upregulate endogenous detoxification enzymes [5]. Chronic exposure or inadequate clearance of these electrophiles is strongly associated with the pathogenesis of cancer, neurodegeneration, and organ toxicity [6].

Other names
Reactive electrophilesElectrophilic speciesReactive metabolitesElectrophilic stressors
02

Biological functions

Cellular stress responseRedox signalingProtein modificationDNA damage inductionApoptosis induction
03

Disease associations

CancerInflammationNeurodegenerative diseaseHepatotoxicityCardiovascular disease
04

Safety considerations

Off-target covalent binding to essential proteinsIdiosyncratic drug-induced liver injury (DILI)Depletion of cellular antioxidant poolsPotential for mutagenicity and carcinogenicity
05

Interacting drugs

N-acetylcysteine

4 more in the full profile.

06

Biomarkers

Glutathione (GSH) levelsProtein carbonyls8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)4-hydroxynonenal (4-HNE) adducts

Beyond the preview

Go deeper on Electrophilic xenobiotics and endogenous electrophilic metabolites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Electrophilic xenobiotics and endogenous electrophilic metabolites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call